Head-to-head · WeighScore
Remote Pharmacy vs TeleHealth Med
By GLP-1 ScorecardUpdated
Score comparison
Remote Pharmacy has the higher recorded score — 69.9/100 to 66.1/100.
Remote Pharmacy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Remote Pharmacy is a US direct-to-consumer telehealth service offering compounded GLP-1 weight-loss medication on a cash-pay basis with no subscriptions or hidden fees.
Before you choose
Before comparing the headline prices, the Remote Pharmacy review and the TeleHealth Med review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Remote Pharmacy vs Tyde Wellness and Rivo Health vs TeleHealth Med compare each of them with another graded program, and the list of alternatives to Remote Pharmacy ranks the programs closest to Remote Pharmacy on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Remote Pharmacy | TeleHealth Med |
|---|---|---|
| WeighScore | 69.9/100 | 66.1/100 |
| Grade | C | C |
| Site position | #124 | #222 |
| Semaglutide | $139/mo month-to-month ($100/mo on 12-month supply, $1,199 upfront; compounded) | $147/mo (starting dose, compounded) |
| Tirzepatide | $159/mo month-to-month ($125/mo on 12-month supply, $1,499 upfront; compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Low cash-pay pricing with no subscription or hidden fees
- Free doctor consultation and free shipping (you pay only for medication)
- Offers injectable and sublingual or tablet forms of both drugs
- Medication made by 503A-certified compounding facilities
What to consider
- Does not publicly name its specific compounding pharmacies or clinical provider
- Covered states are not listed on the pages reviewed
- Newer brand with limited third-party track record
Strengths
- Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
- Publishes the FDA compounded-medication disclaimer
- 503A pharmacy designation stated in the FAQ
- Honest disclosure that testimonials are compensated and results aren't independently verified
- Both injectable and sublingual forms offered
What to consider
- Specific 503A pharmacy partner not named
- LegitScript ID number not shown in text — only a verification link
- Full states-served list not disclosed
- Named medical director not disclosed
- Dose tiers beyond the $147/mo starting price not published
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.